IP Library Patent Application 16156276
Patent Application
App. No. 16/156,276

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/156,276
Abstract

The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably comprise aceclidine and a cryoprotectant. The compositions optionally contain a cycloplegic agent, a surfactant, a viscosity enhancer, an osmolarity modifier and a preservative.

Claims (26)

1 . A method of stabilizing a composition comprising aceclidine comprising storing the composition in a container having a headspace at a temperature from about 2 degrees Celsius to about 8 degrees Celsius.

2 . The method of claim 1 , wherein the composition is filled into the container under a nitrogen overlay.

3 . The method of claim 2 , wherein the headspace is purged with nitrogen.

4 . The method of claim 1 , wherein aceclidine is at a concentration from about 0.25% to about 4.0% w/v aceclidine, wherein w/v denotes weight by total volume of the composition.

5 . The method of claim 1 , wherein the method provides at least 90% stability of aceclidine for at least 7 months.

6 . The method of claim 3 , wherein the method provides at least 90% stability of aceclidine for at least 12 months.

7 . The method of claim 1 , wherein the composition further comprises a viscosity enhancer, a polysorbate, a cryoprotectant and a preservative.

8 . The method of claim 7 , wherein the method provides at least 90% stability of aceclidine for at least 18 months.

9 . The method of claim 7 , wherein the viscosity enhancer provides a viscosity of at least 50 centipoise.

10 . The method of claim 7 , wherein the cryoprotectant is selected from the group consisting of a polyol, a sugar, an alcohol, a lower alkanol, a lipophilic solvent, a hydrophilic solvent, a bulking agent, a solubilizer, a surfactant, an antioxidant, a cyclodextrin, a maltodextrin, colloidal silicon dioxide, polyvinyl alcohol, 2-methyl-2,4-pentanediol, cellobiose, gelatin, polyethylene glycol (PEG), dimethyl sulfoxide (DMSO), formamide, antifreeze protein 752 or a combination thereof.

11 . The method of claim 7 , wherein the preservative is selected from the group consisting of benzalkonium chloride, sorbate, an antioxidant and a combination thereof.

12 . The method of claim 9 , wherein the antioxidant is selected from the group consisting of sodium ascorbate, sodium bisulfate, sodium metabisulfite, n-acetyl cysteine and a combination thereof.

13 . A method of stabilizing a composition comprising aceclidine, hydroxypropylmethyl cellulose, polysorbate 80, mannitol, sorbate and an antioxidant selected from the group consisting of sodium ascorbate, sodium bisulfate, sodium metabisulfite, n-acetyl cysteine or a combination thereof comprising storing the composition in a container having a headspace at a temperature from about 2 degrees Celsius to about 8 degrees Celsius, wherein the composition is filled into the container under a nitrogen overlay and the headspace is purged with nitrogen.

14 . The method of claim 13 , wherein the aceclidine is at a concentration from about 0.25% to about 4.00% w/v, the hydroxypropylmethyl cellulose is at a concentration from about 0.75% to about 1.25% w/v, polysorbate 80 is at a concentration from about 2% to about 4% w/v, mannitol is at a concentration from about 2% to about 4% w/v, sorbate is at a concentration from about 0.10% to about 0.12% w/v and the antioxidant is at a concentration from about 0.10% to about 0.25% w/v, wherein w/v denotes weight by total volume of the composition.

15 . The method of claim 14 , wherein the method provides at least 90% stability of aceclidine for at least 20 months.

16 . The method of claim 15 , wherein the method provides at least 90% stability of aceclidine for at least 22 months.

17 . A container comprising aceclidine prepared by the process comprising the steps of:

a) providing a container;

b) filling the container with a composition comprising aceclidine under a nitrogen overlay;

c) purging a headspace created during the filling step b) with nitrogen;

d) capping the container.

18 . The container of claim 17 , wherein the process further comprises the step of storing the container at a temperature from about 2 to about 8 degrees Celsius.

19 . The container of claim 17 , wherein the composition further comprises a preservative selected from the group consisting of sorbate, benzalkonim chloride, sodium ascorbate, sodium bisulfate, sodium metabisulfite, n-acetyl cysteine and a combination thereof.

20 . The container of claim 17 , wherein the composition has a viscosity of at least 50 centipoise.

21 . A composition comprising from about 0.25% to about 4.0% w/v aceclidine and one or more means of stabilizing the composition selected from the group consisting of filling the composition into a container under a nitrogen overlay and purging a headspace created during filling with nitrogen, having a total viscosity of the composition of at least 50 centipoise or more, adding a preservative to the composition selected from the group consisting of sorbate, benzalkonim chloride, sodium ascorbate, sodium bisulfate, sodium metabisulfite, n-acetyl cysteine and a combination thereof,

wherein the composition is stored at a temperature from about 2 to about 8 degrees Celsius and wherein w/v denotes weight by total volume of the composition.

Assignments (4)
CHANGE OF NAME Recorded Apr 8, 2024
From: LENZ THERAPEUTICS, INC.
To: LENZ THERAPEUTICS OPERATIONS, INC.
Reel/Frame 067625/0816 →
CHANGE OF NAME Recorded Apr 3, 2024
From: PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 067002/0157 →
CHANGE OF NAME Recorded Nov 9, 2020
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 054363/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2020
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES, LLC
Reel/Frame 052849/0632 →